Ethanolamine
( DrugBank: Ethanolamine / KEGG DRUG: Monoethanolamine )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 60 | Aplastic anemia | 3 |
| 63 | Idiopathic thrombocytopenic purpura | 2 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion | 2 |
60. Aplastic anemia
Clinical trials : 357 / Drugs : 477 - (DrugBank : 94) / Drug target genes : 57 - Drug target pathways : 184
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
63. Idiopathic thrombocytopenic purpura
Clinical trials : 868 / Drugs : 544 - (DrugBank : 96) / Drug target genes : 82 - Drug target pathways : 195
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
Clinical trials : 28 / Drugs : 36 - (DrugBank : 15) / Drug target genes : 6 - Drug target pathways : 138
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|